203 related articles for article (PubMed ID: 3777947)
1. [Recent circumstances in the supply and demand of various blood products in Japan, and appropriate use of blood components or plasma protein derivatives].
Tohyama H
Gan To Kagaku Ryoho; 1986 Oct; 13(11):3095-104. PubMed ID: 3777947
[TBL] [Abstract][Full Text] [Related]
2. Pediatric hemostasis and use of plasma components.
Goldenberg NA; Manco-Johnson MJ
Best Pract Res Clin Haematol; 2006; 19(1):143-55. PubMed ID: 16377547
[TBL] [Abstract][Full Text] [Related]
3. Plasma exchange donation of cryoprecipitate after DDAVP stimulation: an alternative source of factor VIII.
McLeod BC; Scott JP
Prog Clin Biol Res; 1990; 324():189-98. PubMed ID: 2106687
[TBL] [Abstract][Full Text] [Related]
4. [Past, present, future use of blood substitutes and plasma substitutes in Japan].
Toyama H
Masui; 1985 Apr; 34(4):515-29. PubMed ID: 4021100
[No Abstract] [Full Text] [Related]
5. [Indications for blood products].
Vezon G
Rev Prat; 1989 Sep; 39(20):1752-61. PubMed ID: 2814258
[TBL] [Abstract][Full Text] [Related]
6. Fresh frozen plasma use in a tertiary referral hospital.
Nicholls MD; Au-Yeung D; Iannella M
J Qual Clin Pract; 1994 Jun; 14(2):77-84. PubMed ID: 8049856
[TBL] [Abstract][Full Text] [Related]
7. Artificial blood and the National Blood Policy.
Surgenor DM; Mierzwa BD
Fed Proc; 1975 May; 34(6):1518-21. PubMed ID: 1126451
[TBL] [Abstract][Full Text] [Related]
8. Clinical use of blood, blood components and blood products.
Blajchman MA; Shepherd FA; Perrault RA
Can Med Assoc J; 1979 Jul; 121(1):33-42. PubMed ID: 466591
[TBL] [Abstract][Full Text] [Related]
9. [Collection and utilization of plasma in Austria: on the way to national self-sufficiency].
Bergmann H; Lukas M; Prusa P
Beitr Infusionsther Transfusionsmed; 1996; 33():103-10. PubMed ID: 8974681
[TBL] [Abstract][Full Text] [Related]
10. [Estimation of the blood donation necessary for self-sufficiency of blood products].
Pinto V; Hernández Mejía R; Cueto A
Sangre (Barc); 1999 Feb; 44(1):38-43. PubMed ID: 10323095
[TBL] [Abstract][Full Text] [Related]
11. [Therapy using blood components. Prerequisites, indications and clinical use].
Glück D; Kubanek B; Ahnefeld FW
Infusionsther Klin Ernahr; 1986 Oct; 13(5):240-9. PubMed ID: 3804436
[TBL] [Abstract][Full Text] [Related]
12. Human albumin solutions: consensus statements for use in selected clinical situations. Subcommittee of the Victorian Drug Usage Advisory Committee.
Med J Aust; 1992 Sep; 157(5):340-3. PubMed ID: 1435481
[TBL] [Abstract][Full Text] [Related]
13. Present status of the usage of blood products and its impact on blood program and clinical medicine: how to balance supply and demand for blood self-sufficiency.
Shimizu M
Nihon Ketsueki Gakkai Zasshi; 1987 Dec; 50(8):1531-41. PubMed ID: 3447408
[No Abstract] [Full Text] [Related]
14. Effects of intravascular volume therapy using hydroxyethyl starch (130/0.4) on post-operative bleeding and transfusion requirements in children undergoing cardiac surgery: a randomized clinical trial.
Chong Sung K; Kum Suk P; Mi Ja Y; Kyoung Ok K
Acta Anaesthesiol Scand; 2006 Jan; 50(1):108-11. PubMed ID: 16451158
[TBL] [Abstract][Full Text] [Related]
15. Testing of blood products in a polytrauma model: results of a multi-institutional randomized preclinical trial.
Alam HB; Bice LM; Butt MU; Cho SD; Dubick MA; Duggan M; Englehart MS; Holcomb JB; Morris MS; Prince MD; Schreiber MA; Shults C; Sondeen JL; Tabbara M; Tieu BH; Underwood SA;
J Trauma; 2009 Oct; 67(4):856-64. PubMed ID: 19820596
[TBL] [Abstract][Full Text] [Related]
16. Physiological aspects of the role of human albumin in the treatment of chronic and acute blood loss.
Schwartzkopff W; Schwartzkopff B; Wurm W; Frisius H
Dev Biol Stand; 1980; 48():7-30. PubMed ID: 7274568
[TBL] [Abstract][Full Text] [Related]
17. An FFP:PRBC transfusion ratio >/=1:1.5 is associated with a lower risk of mortality after massive transfusion.
Sperry JL; Ochoa JB; Gunn SR; Alarcon LH; Minei JP; Cuschieri J; Rosengart MR; Maier RV; Billiar TR; Peitzman AB; Moore EE;
J Trauma; 2008 Nov; 65(5):986-93. PubMed ID: 19001962
[TBL] [Abstract][Full Text] [Related]
18. Developments in component therapy: novel components and new uses for familiar preparations.
Wright-Kanuth MS; Smith LA
Clin Lab Sci; 2002; 15(2):116-24; quiz 125-7. PubMed ID: 12776775
[TBL] [Abstract][Full Text] [Related]
19. Transfusion utilization during adnexal or peritoneal cancer surgery: effects on symptomatic venous thromboembolism and survival.
Abu-Rustum NR; Richard S; Wilton A; Lev G; Sonoda Y; Hensley ML; Gemignani M; Barakat RR; Chi DS
Gynecol Oncol; 2005 Nov; 99(2):320-6. PubMed ID: 16061278
[TBL] [Abstract][Full Text] [Related]
20. Pathogen reduction of blood components.
Solheim BG
Transfus Apher Sci; 2008 Aug; 39(1):75-82. PubMed ID: 18602343
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
